Merus has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $150,000,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, Merus is raising $150,000,000.00 in new funding. About Merus: Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands….